AI reads skin scars to predict who will beat melanoma

NCT ID NCT05856565

First seen Apr 23, 2026 · Last updated May 07, 2026 · Updated 2 times

Summary

This study aims to create an artificial intelligence tool that analyzes photos of skin damage around a melanoma scar to predict whether a patient will respond to anti-PD-1 immunotherapy. Researchers will enroll 700 adults with advanced melanoma or other skin cancers. The goal is to offer a simple, non-invasive way to choose the best treatment for each person.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ambroise Paré Hospital - APHP

    NOT_YET_RECRUITING

    Paris, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Angers University Hospital

    RECRUITING

    Angers, Maine-et-Loire, 49000, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Avicenne Hospital - APHP

    NOT_YET_RECRUITING

    Paris, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Besancon University Hospital

    RECRUITING

    Besançon, Bourgogne-Franche-Comté, 25000, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Bichat Hospital - APHP

    NOT_YET_RECRUITING

    Paris, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Blois Hospital site

    NOT_YET_RECRUITING

    Blois, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Bordeaux University Hospital

    NOT_YET_RECRUITING

    Bordeaux, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Brest University Hospital

    RECRUITING

    Brest, Finistère, 29000, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CH du Mans

    NOT_YET_RECRUITING

    Le Mans, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • CHU de La Rochelle

    NOT_YET_RECRUITING

    La Rochelle, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • CHU de Rennes

    NOT_YET_RECRUITING

    Rennes, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Dijon University Hospital

    NOT_YET_RECRUITING

    Dijon, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Eugène Marquis site - Rennes

    NOT_YET_RECRUITING

    Rennes, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Grenoble University Hospital

    NOT_YET_RECRUITING

    Grenoble, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • ICO

    NOT_YET_RECRUITING

    Saint-Herblain, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Léon Site Bérard in Lyon

    NOT_YET_RECRUITING

    Lyon, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Nantes University Hospital

    RECRUITING

    Nantes, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Rouen University Hospital

    NOT_YET_RECRUITING

    Rouen, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Saint-Louis Hospital - APHP

    NOT_YET_RECRUITING

    Paris, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Valence Hospital Site

    NOT_YET_RECRUITING

    Valence, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.